Abstract:Objective To investigate the relationships between adiponectin gene( ADIPOQ)DNA methylation and non-alcoholic fatty liver diseases( NAFLD)in rats. Methods 24 SD rats were selected and were divided into three groups,normal group,NAFLD model group and curcumin group. The blood biochemical indicators of every rat were tested. RT-PCR and bisulfite cloning sequencing method( BSP)are applied to assess the adiponectin gene mRNA expression of rat,s livers and the degree of methylation. These indexes were compared the differences between the two groups. Results ①The serum ALT,TG,TC,blood sugar of NAFLD group rats significantly increased( P <0. 05),compared to the normal rats. The serum indicators of Curcumin group rats were reversed compared to NAFLD group( P <0. 05). ②The adiponectin mRNA ex-pression rates of NAFLD model groupˊs livers were significantly lower than that of normal group,the expression rates of curcumin group increased compare to NAFLD model group( P <0. 05). ③The degree of adiponectin methylation in NAFLD groupˊs livers were obviously higher than that of normal rats,after giving curcumin to demethylation. The degree of methylation fell slightly. To analyze a total of 10 CpG sites on adiponectin promoter region,in addition to the CpG1679 and 1714sites,the rates of methylation in other sites were higher than in normal group. However,the DNA methylation levels at CpG 1629,1641,1669,1690,1708,1791sites and the mean methylation level were much higher than that(all P <0. 05). After 4 weeks of curcumin interferenced,in addition to the CpG1679,1714sites,the rates of methylation in other sites were lower than the NAFLD group. However,the DNA methylation levels at CpG 1641,1669,1690,1708,1791sites were much lower than that(all P <0. 05). Conclusion ①After curcumin treatment,the serum indexes of rats improved,it means curcumin plays an important role in protecting liver,low-ering lipid,lowering hypoglycemic. ②DNA methylation may be one of the pathogenesis of NAFLD,curcumin may increase adiponectin mRNA ex-pression by lowering adiponectin promoter CpG methylation levels,to reduce the hepatic steatosis of NAFLD rat models. ③Abnormal expression of adiponectin gene is closely related to the gene promoter region methylation.

The Expression and CpG Island Methylation of PNPLA3 in Experimental Nonalcoholic Fatty Liver Disease

Expressions of Key Regulatory Genes of the Lipid Metabolism in Livers During the Development of Rat Non-alcoholic Fatty Liver Disease

Aberrant Hepatic Microrna Expression in Nonalcoholic Fatty Liver Disease

PNPLA3 Rs139051 is Associated with Phospholipid Metabolite Profile and Hepatic Inflammation in Nonalcoholic Fatty Liver Disease

Fatty Liver Mediated by Peroxisome Proliferator‐activated Receptor‐α DNA Methylation Can Be Reversed by a Methylation Inhibitor and Curcumin

Long Non-Coding Rna Profiling In A Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight Into Pathogenesis

PNPLA 3 I 148 M Variant in Nonalcoholic Fatty Liver Disease : Demographic and Ethnic Characteristics and the Role of the Variant in Nonalcoholic Fatty Liver Fibrosis

The Role of Adipoq Methylation in Curcumin-Administrated Experimental Nonalcoholic Fatty Liver Disease

Effect of methylation status of adiponectin gene promoter region on rats with experimental non-alcoholic fatty liver diseases

N-3 Polyunsaturated Fatty Acids in Phospholipid or Triacylglycerol Form Attenuate Nonalcoholic Fatty Liver Disease Via Mediating Cannabinoid Receptor 1/adiponectin/ceramide Pathway.

Identification of gene expression patterns in rat model of nonalcoholic fatty liver disease

Analysis of Pirna Expression Spectra in a Non-Alcoholic Fatty Liver Disease Mouse Model Induced by a Methionine- and Choline-Deficient Diet.

PNPLA3 Rs738409 Underlies Treatment Response in Nonalcoholic Fatty Liver Disease

Effect of High Fat on Expressions of Hepatic NLRP3 Inflammasome-related Genes in vivo and in vitro

Genome-Wide Analysis Of Dna Methylation In Human Peripheral Leukocytes Identifies Potential Biomarkers Of Nonalcoholic Fatty Liver Disease

Association between patatin-like phospholipase domain-containing protein 3 gene rs738409 polymorphism and non-alcoholic fatty liver disease susceptibility: a Meta-analysis

Downregulation of GNAI3 Promotes the Pathogenesis of Methionine/Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease

Polymorphism Rs738409 in PNPLA3 is Associated with Inherited Susceptibility to Non-Alcoholic Fatty Liver Disease

PNPLA3 I148M mediates the regulatory effect of NF-kB on inflammation in PA-treated HepG2 cells

Integrating Multi-Omics Reveals Crucial Biomarkers in Non-Alcoholic Fatty Liver Disease

Association Between PNPLA3 Rs738409 Polymorphism and Nonalcoholic Fatty Liver Disease (NAFLD) Susceptibility and Severity